ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

A real-world study showed HER2DX guided treatment changes in approximately 48% of HER2-positive breast cancer cases.

In addition to determining the hormone receptor and HER2 protein status, healthcare teams use the TNM system to identify the ...

Not significant different from CISH HER2 signals in a two tailed, paired t-test (N = 348, P = 0.245) d) Not significant different from CISH HER2 signals in a two-tailed, paired t-test (N = 350 ...

Now, those patients with low HER2 status might be eligible for targeted treatment and a significant potential improvement in outcome, as they will be considered for the specifically engineered ...

Patients and Methods: A total of 320 patients with AOC were centrally screened for HER2 status (243 patients in fi rst line, 77 in relapse). All positive (IHC 3+) and doubtful (IHC 2+) cases were ...

Timely receipt of guideline-concordant care can improve survival and may help mitigate racial and ethnic disparities in survival among patients with inflammatory breast cancer, researchers wrote.

Forward steps are being made in HNSCC, and the first patient with MDS has been treated with iadademstat/azacitidine.

Income tax expense increased by $6.7 million in 2024 compared to 2023, primarily due to an increase in U.S. taxes under the ...